Sponsor or institution

Clinical trials and research at Alebund Pharmaceuticals

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• AP301, an iron-based phosphate binder, for people on dialysis with high blood phosphate

  This study will test whether the iron-based drug AP301 can lower high blood phosphate in people with end-stage kidney disease who are on maintenance dialysis.

  Recruiting at 41 sites Phase 3 Alebund Pharmaceuticals · Granada Hills, California and 41 other locations · NCT06933472

• AP303 safety, tolerability, and dosing in people with diabetic kidney disease

  This study will try a 2-week oral dose of AP303 or placebo in adults with type 2 diabetic kidney disease to see if it is safe and how the body processes it.

  Recruiting Phase 1 Alebund Pharmaceuticals · Beijing, Beijing Municipality · NCT06666283

Quick answers

How many clinical trials run by Alebund Pharmaceuticals are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →